NCT06663943
A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313. treatment 1 / 2 not_yet_recruiting NCT06654817
Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris Not Available Not Available completed NCT00683930
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV) treatment 3 completed NCT04422912
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV) No drug interventions treatment 1 recruiting NCT04598451
A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) treatment 3 completed NCT04598477
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) treatment 3 terminated NCT02753777
Autoimmune Blistering Diseases Study No drug interventions Not Available Not Available recruiting NCT00063752
Safety Study of PI-0824 to Treat Pemphigus Vulgaris treatment 1 completed NCT01930175
Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris treatment 2 terminated NCT03239470
Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus No drug interventions treatment 1 terminated NCT04023149
Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris treatment 2 unknown_status NCT00606749
Use of KC706 for the Treatment of Pemphigus Vulgaris treatment 2 completed NCT03780166
A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris treatment 2 withdrawn NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives No drug interventions Not Available Not Available recruiting NCT05594472
Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid treatment 3 recruiting NCT04540133
Dexamethasone Solution and Dexamethasone in Mucolox™ treatment 2 completed NCT00429533
Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris treatment 2 terminated NCT01920477
Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris treatment 3 terminated NCT00626678
Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone treatment 2 completed NCT03177213
Serum IL-21 Levels in Patients With Pemphigus Vulgaris No drug interventions Not Available Not Available unknown_status NCT00483119
Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus treatment 2 terminated NCT05000216
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders prevention 2 completed NCT03334058
A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus treatment 2 completed NCT04096222
Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients No drug interventions Not Available Not Available unknown_status NCT00135720
Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris treatment 2 completed NCT06581562
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. treatment 1 recruiting NCT04117529
Phenotypic and Functional Characterisation of Human B-cell Response in Pemphigus No drug interventions basic_science Not Available unknown_status NCT02704429
A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris treatment 2 completed NCT02383589
A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV) treatment 3 completed NCT03075904
A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus) treatment 1 / 2 terminated NCT05303272
A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV) treatment 4 unknown_status NCT05338112
Role of Tzanck Smear in Determining Pemphigus Vulgaris Disease Activity No drug interventions Not Available Not Available unknown_status NCT06167408
Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients No drug interventions Not Available Not Available completed